GlassScriptPhysician profile
Karma Williams
NPI 1871156711
$11,758.80
in general payments reported to CMS, 2019-2025
46 companies · $1,757 in 2025
The $1,757 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,684 · 2022: $1,488 · 2023: $4,341 · 2024: $2,489 · 2025: $1,757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,222 · Travel and Lodging: $1,311 · Education: $54.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,222.01 |
| Travel and Lodging | $1,310.86 |
| Education | $54.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,507.10 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Activos 10 Bone Cement |
| Abbvie INC. | $1,445.37 | 2021-2025 | |
| Boston Scientific Corporation | $933.95 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Superion Indirect Decompression System |
| Abbott Laboratories | $578.81 | 2023-2025 | Eterna, Proclaim |
| Forte Bio-Pharma LLC | $435.80 | 2021-2025 | Prolate, Nalocet, Tanlor |
| Collegium Pharmaceutical, INC. | $410.67 | 2021-2025 | Belbuca, Nucynta |
| Vertos Medical, INC. | $351.17 | 2021-2022 | |
| Virtus Pharmaceuticals LLC | $324.09 | 2023-2025 | Levorphanol Tartrate |
| Nevro Corp. | $274.08 | 2021-2024 | Senza |
| Pfizer INC. | $272.31 | 2023-2025 | |
| Si-Bone, INC. | $271.75 | 2022-2024 | |
| Scilex Pharmaceuticals INC. | $224.46 | 2021-2023 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $210.56 | 2021-2025 | Relistor |
| Lundbeck LLC | $206.45 | 2021-2023 | Vyepti |
| Azurity Pharmaceuticals, INC. | $165.08 | 2023-2025 | Horizant, Horizant |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karma Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.